QLT Inc. (QLTI) Announces QLT091001 Granted Orphan Drug Designation by the U.S. FDA
Tweet Send to a Friend
QLT Inc. (Nasdaq: QLTI) announced that their QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
